A robust mRNA signature obtained via recursive ensemble feature selection predicts the responsiveness of omalizumab in moderate‐to‐severe asthma

Sarah Kidwai, Pietro Barbiero, Irma Meijerman, A. Tonda, P. Perez‐Pardo, Pietro Liò, Anke H. van der Maitland‐Zee, D. Oberski, A. Kraneveld, A. Lopez-Rincon

Author Locations

No location data available for the ELLIS authors of this paper.

ELLIS Edge Newsletter
Join the 6,000+ people who get the monthly newsletter filled with the latest news, jobs, events and insights from the ELLIS Network.